{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:04:14Z","timestamp":1793340254230,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,19]],"date-time":"2027-03-19T00:00:00Z","timestamp":1805414400000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"NEI","doi-asserted-by":"publisher","award":["5 K23 EY032204-02"],"award-info":[{"award-number":["5 K23 EY032204-02"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ogla.2025.10.003","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:11:32Z","timestamp":1760695892000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Effect of Medication Adherence on Intraocular Pressure and Glaucoma Progression"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6769-5519","authenticated-orcid":false,"given":"Louay","family":"Almidani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jithin","family":"Yohannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2025.10.003_bib1","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ogla.2025.10.003_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamaophthalmol.2021.0527","article-title":"Prevalence of visual acuity loss or blindness in the US","volume":"139","author":"Flaxman","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2025.10.003_bib3","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamaophthalmol.2022.2405","article-title":"County-level variation in the prevalence of visual acuity loss or blindness in the US","volume":"140","author":"Lundeen","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2025.10.003_bib4","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ogla.2025.10.003_bib5","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41433-024-02995-5","article-title":"Global estimates on the number of people blind or visually impaired by glaucoma: a meta-analysis from 2000 to 2020","volume":"38","author":"Bourne","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.ogla.2025.10.003_bib6","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2025.10.003_bib7","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.10.003_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The Most common barriers to glaucoma medication adherence","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0002-9394(86)90940-2","article-title":"Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?","volume":"101","author":"Kass","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2025.10.003_bib11","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","article-title":"Adherence and persistence with glaucoma therapy","volume":"53","author":"Schwartz","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ogla.2025.10.003_bib12","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2005.10.034","article-title":"Patient-reported behavior and problems in using glaucoma medications","volume":"113","author":"Sleath","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib13","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.ophtha.2011.05.013","article-title":"The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity","volume":"118","author":"Sleath","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ophtha.2019.08.027","article-title":"Evidence-based criteria for determining peripapillary OCT reliability","volume":"127","author":"Yohannan","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ophtha.2023.03.019","article-title":"Predicting visual field worsening with longitudinal optical coherence tomography data using a gated transformer network","volume":"130","author":"Hou","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib17","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.ogla.2025.10.003_bib18","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"Tsai","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib19","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1167\/iovs.07-0290","article-title":"Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the glaucoma adherence and persistency study (GAPS)","volume":"48","author":"Friedman","year":"2007","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2025.10.003_bib20","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","article-title":"Patterns of glaucoma medication adherence over four years of Follow-Up","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/eye.2000.197","article-title":"Compliance and viewpoint of glaucoma patients in Greece","volume":"14","author":"Konstas","year":"2000","journal-title":"Eye"},{"key":"10.1016\/j.ogla.2025.10.003_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular HypertensionAn evidence-based review","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2025.10.003_bib23","article-title":"Whitecoat adherence in patients with primary open-angle glaucoma","volume":"9","author":"Poleon","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ogla.2025.10.003_bib24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/eye.2011.111","article-title":"Association between intraocular pressure and adherence: is there one?","volume":"25","author":"Cate","year":"2011","journal-title":"Eye"},{"key":"10.1016\/j.ogla.2025.10.003_bib25","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/IJG.0000000000001943","article-title":"Topical medication adherence and visual field progression in open-angle glaucoma: analysis of a large US health care system","volume":"30","author":"Shu","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ogla.2025.10.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100953","article-title":"Adaptive responses to neurodegenerative stress in glaucoma","volume":"84","author":"Calkins","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ogla.2025.10.003_bib27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2007.03.042","article-title":"Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data","volume":"114","author":"Quigley","year":"2007","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419625002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419625002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:36:23Z","timestamp":1773912983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419625002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2589419625002145"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2025.10.003","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Medication Adherence on Intraocular Pressure and Glaucoma Progression","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2025.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}